drugset / Trial / NCT03168997
Memantine Treatment in Alzheimer's Disease Patients
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to investigate whether there will be any efficacy difference of Memantine treatment in different cognitive severity AD patients stratified with BPSD
Timeline
- Start
- 2017-07-15
- Primary completion
- 2018-09-30
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 20 mg | Oral |